The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH

NCT07134907 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

BPH (Benign Prostatic Hyperplasia)

Interventions

DRUG: Silodosin
DRUG: Tamsolusin

Sponsor

Shanghai Huilun Pharmaceutical Co., Ltd.